The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience
- PMID: 10981645
- DOI: 10.1191/096120300678828569
The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience
Abstract
We have evaluated the incidence of lupus erythematosus (LE)-specific skin disease in 186 patients with LE, seen retrospectively over a 10-year period at our Dermatology Department and determined the correlation of LE-nonspecific skin disease in patients with systemic involvement. Chronic cutaneous LE (CCLE) with classical discoid lesions (localized, 70%; generalized, 30%) was the most common cutaneous manifestation (72.5%). Subacute cutaneous LE (SCLE) represented only 8% of LE skin disease (annular-polycyclic type, 73%; papulo-squamous type, 27%). Acute cutaneous LE (ACLE) was detected in 15% of our patients: the butterfly erythema was the most frequent skin lesion (96%) while only one case of bullous LE and one case of widespread maculo-papular eruption in association with malar erythema were demonstrated. In 8 patients no LE-specific skin lesions (lupus sine lupo) were found. LE-nonspecific skin lesions were found in 31% of our patients with systemic LE (SLE): Raynaud's phenomenon was found in 23/58 (39.6%), cutaneous small vessel leukocytoclastic vasculitis in 8/58 (13.7%), nonscarring alopecia in 18/58 (31%), lupus pernio in 6/58 (10.3%), hemorrhagic lesions in 4/58 (6.8%), livedo reticularis in 5/58 (8.6%), mucosal ulcers in 3/58 (5.1%) and periungual telangiectasia in 12/58 (20.6%) SLE patients. LE-nonspecific skin lesions are detected only in patients with SLE and usually in the active phases of the disease.
Similar articles
-
Clinicopathological characteristics of cutaneous lupus erythematosus patients in Bangladesh.Postepy Dermatol Alergol. 2022 Aug;39(4):782-787. doi: 10.5114/ada.2021.110254. Epub 2021 Oct 22. Postepy Dermatol Alergol. 2022. PMID: 36090729 Free PMC article.
-
Cutaneous manifestations of systemic lupus erythematosus.Br J Dermatol. 1996 Sep;135(3):355-62. Br J Dermatol. 1996. PMID: 8949425
-
Cutaneous lupus erythematosus: issues in diagnosis and treatment.Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19824738 Review.
-
Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.Br J Dermatol. 2010 Jan;162(1):91-101. doi: 10.1111/j.1365-2133.2009.09472.x. Epub 2009 Sep 28. Br J Dermatol. 2010. PMID: 19785596
-
Clinical course and prognosis of cutaneous lupus erythematosus.Clin Dermatol. 2004 Mar-Apr;22(2):121-4. doi: 10.1016/j.clindermatol.2003.12.018. Clin Dermatol. 2004. PMID: 15234012 Review.
Cited by
-
Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview.Curr Treat Options Cardiovasc Med. 2004 Apr;6(2):87-97. doi: 10.1007/s11936-004-0036-1. Curr Treat Options Cardiovasc Med. 2004. PMID: 15066237
-
The Burden of Living With Cutaneous Lupus Erythematosus.Front Med (Lausanne). 2022 Aug 8;9:897987. doi: 10.3389/fmed.2022.897987. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36017007 Free PMC article. Review.
-
Clinicopathological characteristics of cutaneous lupus erythematosus patients in Bangladesh.Postepy Dermatol Alergol. 2022 Aug;39(4):782-787. doi: 10.5114/ada.2021.110254. Epub 2021 Oct 22. Postepy Dermatol Alergol. 2022. PMID: 36090729 Free PMC article.
-
Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin.ScientificWorldJournal. 2014 Mar 11;2014:925805. doi: 10.1155/2014/925805. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24744689 Free PMC article.
-
Treatment With Voclosporin and Anifrolumab in a Patient With Lupus Nephritis and Refractory Discoid Lupus Erythematosus: A Case Report and Literature Review.Cureus. 2024 Mar 1;16(3):e55321. doi: 10.7759/cureus.55321. eCollection 2024 Mar. Cureus. 2024. PMID: 38559540 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical